Rutgers & Posch assists shareholders with the sale of a majority stake in Verklizan to Main Capital

16 June 2017

Main Capital has acquired a majority stake in the international software company Verklizan. Verklizan delivers an innovative, cloud-based, Connected Healthcare platform for social alarms and remote care.

Verklizan is a Dutch supplier of the UMO platform, a platform for social alarming, remote care, welfare and safety. With more than 60 employees spread across offices in the Netherlands, Germany, England, France and Spain, Verklizan serves more than 300 customers worldwide Verklizan is characterized by its open platform philosophy that supports the connection of the UMO platform with more than 250 healthcare products and technological developments of over 100 product partners. This gives the customers of Verklizan the freedom and opportunity to continuously provide the best and technologically most advanced remote care.

Main Capital is a private equity and Mezzanine Capital investor with an exclusive focus on the software sector in the Benelux and DACH area. As a majority shareholder Main Capital will actively support Verklizan in their quest to grow the company internationally. In addition, focus will be on further strengthening and expanding the product portfolio, among others through selective and complementary acquisitions.

Matthijs van den Broek and Hjalmar Florijn from Rutgers & Posch acted as legal advisors for the selling shareholders of Verklizan.